Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104232730A details enzymatic resolution for high-purity intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN114703169A reveals a novel L-threonine aldolase mutant for Droxidopa. Achieves 92.89% selectivity. Ideal for pharma intermediates supply.
Novel chiral phase transfer catalyst enables high-purity S-2-6-dimethyl tyrosine production with significant cost reduction and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN117143094A reveals a novel biphasic synthesis for Apixaban intermediates. Achieve higher purity and yield with simplified equipment for reliable supply chain integration.
Novel solid-phase method improves Velcalcetide yield and purity, offering supply chain reliability for pharmaceutical intermediates manufacturers.
Patent CN105837410B reveals a robust nanoporous palladium method for cis-olefin production offering significant supply chain stability and cost reduction potential for pharmaceutical intermediates manufacturing globally.
Patent CN106397542A reveals high-yield microwave synthesis for triptorelin acetate. Achieve 99% purity and reduced costs with scalable pharmaceutical intermediate solutions.
Patent CN1442407A details a cost-effective resolution method for fexofenadine intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical partners.
Patent CN102146079A reveals a solvent-free quaternization process enhancing yield to 82%. Discover cost reduction in API manufacturing and supply chain reliability.
Patent CN106701723B details FSAA mutants for chiral synthesis. Offers cost reduction in chiral building block manufacturing with high stereoselectivity.
Patent CN117003639B enables high-yield synthesis of methyl o-iodobenzoate. Reduced waste and enhanced purity offer significant supply chain advantages.
Novel patent CN105622382B offers high-yield synthesis for Dapagliflozin intermediates with reduced waste and cost efficiency for global supply chains.
Patent CN107141289A details a novel synthesis for piperidines. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105102425A details a high-yield synthesis route for bile acid derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Patent CN102079720B reveals a mild TEMPO-catalyzed route for high-purity 1-benzyl-4-piperidinealdehyde, offering significant cost reduction and scalability for Alzheimer's drug intermediates.
Patent CN108822085A details a novel purification method achieving 99.5% purity. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Novel synthesis route for cardiovascular intermediates offers higher yield and reduced steps ensuring reliable pharmaceutical intermediate supplier capabilities for global scale.
Patent CN1106399C details a high-yield cyclization method for Sildenafil. This report analyzes cost reduction in pharmaceutical manufacturing and supply chain reliability.
Novel patent CN118164864A offers nitro-free Roxadustat intermediate synthesis. Enhances safety, reduces cost, and ensures supply chain reliability for global pharmaceutical partners.